Conduit Choice and Volume-Outcome Relationships in Multi-Arterial Coronary Artery Bypass Grafting in Medicare Beneficiaries in the United States
Sunday, January 26, 2025
8:40am – 8:50am PT
Location: 403A
D. Tam1, q. chen1, A. Sallam2, S. Fremes3, M. F.L.. Gaudino4, M. E. Bowdish5, J. Chikwe6 1Cedars Sinai Medical Center, Los Angeles, California 2Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 3Sunnybrook Health Science Center, Toronto, Ontario 4Weill Cornell Medicine, New York, New York 5Cedars Sinai Medical Center, La Canada, California 6Cedars-Sinai, Los Angeles, California
Disclosure(s):
Derrick Tam, MD: No financial relationships to disclose
Purpose: Multi-arterial revascularization is under-utilized despite guideline recommendations for coronary bypass (CABG) conduit choice. This study was designed to evaluate the role of surgeon experience on use and outcomes of multi-arterial revascularization. Methods: Using US Centers for Medicare and Medicaid data, we identified 9,516 patients undergoing isolated, primary, non-emergency multi-arterial revascularization including 2,430 (26%) who received radial artery and 7,086 (74%) who received bilateral internal thoracic artery (BITA). Individual surgeons were grouped into tertiles based on conduit use: low volume surgeons performed < 3 radial arteries or 2 BITAs per year, and high-volume surgeons performed >10 or 4 respectively. The primary outcome was all cause mortality. The secondary outcome of major adverse events (MACE) was a composite of death, myocardial infarction, or repeat revascularization compared in a multivariable Cox-proportional hazard model adjusting for 27 pre-operative variables in addition to the individual surgeon’s case volume of each conduit. Patients undergoing multi-arterial grafting were also compared to patients undergoing single arterial grafting(n=18,375), stratified by multi-arterial and overall CABG volume respectively. Results: The median patient age was 72 (IQR: 68-72) and multi-arterial revascularization was used in 34%: those receiving radial artery were younger ( 71.9 vs. 72.6 years) and more likely diabetic (50.9% vs 45.5%) compared to BITA recipients. Adjusted 30-day death was similar (2.0% vs 1.3%, adjusted OR: 0.71, 95%CI: 0.47-1.04, p=0.091). There was no difference in 30-day mortality by surgeon volume tertile in the radial group (1.0%, 1.2%, and 1.7%, p=0.427), however 30-day mortality was 1.4%, 1.8%, and 3.2% (p < 0.001) for high, medium, and low volume BITA users. There was no difference in 4-year mortality between patients receiving radial (87.3%) versus BITA (85.0%) (adjusted HR: 0.85, 95%CI: 0.70-1.02, p=0.087) but freedom from MACE was higher in the radial group (85.2% versus 81.4%) (HR: 0.84, 95%CI: 0.71-0.98, p=0.03). Surgeon experience was not associated with significant differences in long-term outcomes in patients receiving radial artery, but late mortality (Figure A, HR 1.32, 95%CI: 1.08-1.61, p=0.0048) and MACE (Figure B, HR: 1.23, 95%CI: 1.04-1.45, p=0.014) were worst among infrequent users of BITA compared to higher volume surgeons. Compared to single-arterial revascularization, reductions in MACE were associated with multi-arterial revascularization only when used by medium/high volume surgeons (HR: 1.28, 95%CI; 1.09-1.49, p< 0.001). Conclusion: Using radial artery as the second conduit in multi-arterial revascularization was associated with improved event-free survival in patients >65-years, compared to BITA. The benefits of multi-arterial grafting appear negated when surgeons perform fewer than two such operations per year.
Identify the source of the funding for this research project: None